RADX Radiopharm Theranostics Limited
$1.00▼ -1.39%
Healthcare
Other
Volume 17.3K
Avg Volume (10D) 47.1K
Key Metrics & Fundamentals
Market Cap
$14.53M
P/E Ratio
–
Div Yield
0.00%
52W Range
0.90 - 16.25
% vs 50 MA
-41.50%
% vs 200 MA
-73.50%
RSI-14
29.3
MACD Histogram
+0.0300
Beta (1Y vs SPY)
0.63
Free Cash Flow
-$8.74M
Gross Rev
–
Gross Profit
–
EBITDA
–
COGS
–
Operating Exp
–
Operating Income
–
EBIT
–
Pretax Income
–
Net Income
–
Price & Volume History
Loading chart…
Recent News
GE HealthCare Wins Approval for MINItrace Magni Cyclotron in Europe
Zacks · Oct 20, 2026 9:00 AM ET
Radiopharm Completes Productive End-of-Phase 2 Meeting with U.S. Food and Drug Administration for Pivotal Development Program of RAD101
GlobeNewswire · Oct 5, 2026 8:00 AM ET
Edison Issues Report on Starpharma (SPL)
TMX Newsfile · Sep 30, 2026 4:23 AM ET
Radiopharm Theranostics Selected for Late-Breaking Oral Presentation of Positive Data from Interim Analysis of U.S. Phase 2b Imaging Trial of RAD101 at 2026 Society of Neuro-Oncology Annual Meeting
GlobeNewswire · Sep 14, 2026 8:00 AM ET
Radiopharm Theranostics Announces Positive Data from the Phase 1 Imaging Trial of RAD301 in Patients with Pancreatic Ductal Adenocarcinoma
GlobeNewswire · Sep 9, 2026 7:00 AM ET
Radiopharm Theranostics Doses First Patient in Second Cohort of Phase 1/2a Clinical Trial of BetaBart (RV-01) in B7-H3 Expressing Solid Tumors
GlobeNewswire · Aug 26, 2026 7:00 AM ET
Radiopharm Theranostics Receives Positive Recommendation from Data Safety and Monitoring Committee to Advance to Cohort 4 in 177Lu-RAD202 Phase 1 HEAT Clinical Trial
GlobeNewswire · Aug 20, 2026 7:00 AM ET
Radiopharm Theranostics To Meet with U.S. FDA to Align on Pivotal Phase 3 Trial Design for RAD 101 in Diagnosis of Brain Metastases
GlobeNewswire · Aug 17, 2026 7:30 AM ET
RADX: RAD101 Topline & FY:26 Cash Flows
Zacks Small Cap Research · Aug 3, 2026 11:14 AM ET
Radiopharm Theranostics Reports Business Update
GlobeNewswire · Jul 31, 2026 7:00 AM ET
Financial Overview - Income Statement
Quarterly
No financial data available. Click Refresh on the ticker to load latest fundamentals.
See RADX's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.